Clinical trial
Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered…
NCT00343421 · Sanofi Pasteur, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00343421 |
|---|---|
| Title | Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers |
| Official title | Immunogenicity and Safety of PEDIACEL®, a Combined Diphtheria, Tetanus, Five Component Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus Influenzae Type b Conjugate Vaccine (Adsorbed), Compared to Infanrix®-IPV+Hib When Both Vaccines Are Co-Administered With Prevenar® to Infants and… |
| Lead sponsor | Sanofi Pasteur, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diphtheria, Tetanus, Pertussis, Poliomyelitis, Haemophilus Influenzae Type b |
| Intervention type | Biological |
| Interventions | PEDIACEL® and Prevenar®, Infanrix®-IPV+Hib and Prevenar® |
| Enrollment | 588 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2009 |
| First posted | Jun 23, 2006 |
| Last update posted | Jun 3, 2016 |
| Countries | France, Poland |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: